Weight loss drugs help with fat loss, but they cause bone and muscle loss too
For a long time, dieting and exercise were the only realistic options for many people who wanted to lose weight, but recent ...
A new weapon in the battle against cancer: The story of combo prodrug TTFA-Platin
Cancer is a deadly disease taking the lives of thousands of people worldwide, and researchers are constantly looking for ...
clinicaladvisor.com1d
FDA Approval Increases Eligibility for Cystic Fibrosis Medication Trikafta
According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment.
Dr. Kube: Diabetes drug lands patient in hospital with pancreatitis
A patient came into the emergency department complaining about nausea, vomiting and abdominal pain. It was something more ...
news24online1d
The Dark Side Of Herbal Green Tea: 7 Side Effects
Green tea, when consumed in excess, can irritate the stomach lining, leading to nausea, acid reflux, or an upset stomach.
Heartbroken dog owner warns of risks after FDA issues alert on arthritis drug
The FDA said there have been more than 8,000 "adverse effects" reported with dogs since the drug was released in May of 2023, ranging from incontinence to seizures and sometimes death.
The American Journal of Managed Care3d
The Challenge of Managing Both Disease Symptoms and Drug Side Effects in Myelofibrosis
There’s a balance required to manage both the symptoms of myelofibrosis through treatment and the side effects caused by the ...
Mediafeed on MSN3d
Cialis Side Effects: What to Expect (& How to Avoid Them)
Cialis — and its generic version, tadalafil — can cause adverse effects at first. Fortunately, most tadalafil side effects ...
Investing14d
FDA expands approval for cystic fibrosis drug Trikafta
TRIKAFTA, a combination of elexacaftor, tezacaftor, and ivacaftor, is designed to enhance the function of the defective protein caused by cystic fibrosis transmembrane conductance regulator (CFTR) ...
Cystic Fibrosis Foundation14d
FDA Approves New, Once-a-Day CFTR Modulator for People With CF
A new CFTR modulator treatment called Alyftrek has been approved for people with CF ages 6 and older who have CFTR mutations ...